Stay updated on Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial
Sign up to get notified when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.

Latest updates to the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page
- ChecktodayChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, particularly in Russia and other countries, while also removing previous location references and some drug information. The content related to human growth hormone and associated medical conditions has been expanded.SummaryDifference10%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or update in the content or functionality.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.